Global clinical trials create Protected Health Information (PHI) in many countries. In many cases, that PHI cannot cross borders. At the same time, organizations still want one AI-driven view of the trial across regions. This often pushes teams to build small, separate regional systems. As a result, expensive GPUs sit idle.
This article explains how to design regional colocation pods. These pods keep PHI compliant in each region. They also deliver the high-throughput storage and predictable networking that production AI workloads need.
The problem: global trials, local PHI
Running global clinical trials while staying compliant with patient-data rules creates two costly problems.
First, PHI cannot freely cross borders. However, global trials still need one combined analysis across regions.
Second, when organizations solve this by building separate regional systems, they often size each region too small. Then the storage and network can’t feed the GPUs fast enough, and the GPUs wait.
PHI is health data that can identify a patient. This includes names, medical record numbers, imaging files, genomic sequences, and test results. It also includes data from Electronic Data Capture (EDC) systems, medical imaging systems, and lab systems. Global trials generate this data in many countries. Each country may have different rules about where the data can live and who can access it.
Compliance failures often happen when data boundaries are not clear. For example, processors may not be correctly designated. Audit trails may have gaps. Or PHI may cross borders by accident through backup copies.
Performance failures happen when distance adds delay. For example, Wide Area Network (WAN) latency can add 50–100 ms to each data request. In addition, some storage systems can only deliver 2 GB/s, even though AI training may need 40 GB/s.
Both failures often come from the same architecture mistake. Teams treat residency as a legal checkbox, instead of a core system design decision.
What "PHI residency" means in practice: classes and boundaries
Data residency means keeping PHI inside specific geographic and legal boundaries. This is not only about storing files in the right country. It also means processing, backups, and administrative access must stay inside those boundaries.
To make this work, organizations need clear rules for three types of data. These types move in different ways:
- PHI: Identifiable clinical data tied to trial subjects that must stay in its region
- De-identified data: Removes direct identifiers but often remains regulated under GDPR
- Derived artifacts: Statistical features, metrics, or AI model weights that typically move more freely
In addition, residency needs operational boundaries, not just a map. In-region storage means primary data, replicas, snapshots, and archives all stay inside the region. In-region key custody means encryption keys stay in regional Key Management Service (KMS) or Hardware Security Module (HSM) systems. In-region admin plane means access controls, audit logging, and incident response operate from inside the region.
For example, consider a pharmaceutical company running a diabetes trial in the US and the EU. Patient records stay in their home regions. However, trained AI model weights can move globally because they do not contain identifiable patient data.
Residency drivers by region: what changes for colocation
Different regions impose different rules. These rules shape both colocation contracts and technical controls. When teams understand the differences early, they avoid compliance gaps that could stop a trial.
In the US, HIPAA requires Business Associate Agreements (BAAs) with any entity that handles PHI. This includes colocation providers that maintain infrastructure that houses the data. In addition, the minimum necessary standard means organizations must show they access only the PHI needed for a specific purpose.
In the EU, GDPR treats health data as special category data and requires an explicit legal basis. After Schrems II, moving EU health data to the US requires extra safeguards. One common safeguard is strong encryption with EU-controlled keys. UK GDPR is similar to EU GDPR, but it uses Integrated Data Transfer Agreements (IDTA) for international transfers.
In APAC, rules vary a lot. Singapore requires breach notification within 72 hours. Japan’s APPI has specific consent requirements. China’s PIPL largely blocks export of health data unless the government approves it.
Because of these differences, the colocation impact is straightforward. Organizations need regional pods with controls that can be enforced locally. Then, after governance review, they centralize only non-PHI artifacts.
Reference architecture: regional PHI pods for clinical trials
A pod is a self-contained regional infrastructure unit. It can run on its own, but it can also support global analysis. Each pod includes what it needs to ingest, process, store, and analyze trial data—without moving PHI across borders.
Each core component supports a specific part of the clinical data pipeline:
- Compute: CPUs for Extract, Transform, Load (ETL) operations plus GPUs for AI workloads
- Storage: High-throughput active tiers delivering 40+ GB/s plus immutable durable tiers for retention
- Network: Deterministic east-west fabric for GPU communication with controlled north-south paths
- Security: Identity management, segmentation, encryption, and audit logging
The pod-to-pod rule is simple. No raw PHI moves between regions. Only approved artifacts move, such as aggregated statistics, trained model weights, or de-identified datasets. Even then, they move only after governance review.
Network and segmentation: keep PHI off the internet
Clinical trial data should not travel across the public internet in readable form. Instead, private connectivity can include MPLS circuits to trial sites, dedicated fiber to Contract Research Organizations (CROs), and VPN tunnels to lab systems.
To enforce boundaries, network segmentation uses several methods:
- Virtual Routing and Forwarding (VRF): Creates isolated routing tables for different trials
- VLANs: Separate traffic at Layer 2 between workloads
- Micro-segmentation: Applies granular firewall rules between individual systems
For AI workloads, fabric design is especially important. High-bandwidth leaf-spine designs reduce the number of hops between GPUs. InfiniBand (IB) or RDMA over Converged Ethernet (RoCE) allows direct memory access between nodes. This can cut latency during distributed training from milliseconds to microseconds.
Storage and data pipelines: design for ingest, not averages
Clinical trials create bursty, ingest-heavy workloads. These workloads are not like steady-state business apps.
For example, one MRI study can produce gigabytes of DICOM files in a short burst. Genomic sequencing can deliver terabytes in very large files. EDC systems often export patient records in scheduled batches.
Because of this, storage sizing should focus on sustained throughput during peak times, not average use. A system may show 20% average utilization and still waste GPU time if it cannot hold 40 GB/s during training data loads.
A common tiering pattern separates needs cleanly:
- Active parallel file systems: Deliver consistent multi-GB/s throughput for training
- S3-compatible object storage: Provide cost-effective retention for archives
- NVMe caching layers: Accelerate frequently accessed datasets
Encryption also has two parts. Data in transit should use TLS 1.3. Data at rest should use AES-256 with keys scoped to the region.
Keys, audit trails, and retention: make inspections boring
Regulatory inspections become routine when governance is built in and runs consistently.
Regional key custody, using KMS or HSM systems, helps keep keys inside the right legal boundary. Some organizations also use Bring Your Own Key (BYOK). In that model, they keep key material in their own HSMs.
Audit needs also require logging that cannot be changed. Centralized immutable logs reduce the risk of tampering. Time sync using NTP helps keep timestamps consistent across systems. In addition, real-time streaming to Security Information and Event Management (SIEM) tools supports fast incident detection.
Retention planning must match trial rules and protocols:
- Clinical trial data: Often 15–25 years post-trial completion
- Audit logs: Typically 7–10 years for regulatory compliance
- Backup validation: Monthly restore tests with Recovery Point Objective (RPO) of 4 hours
Colocation requirements checklist: contracts, controls, and exit
To evaluate regional colocation providers, organizations should review three areas. These areas are contract terms, operating controls, and exit planning.
Contract needs depend on the region. However, they often include Business Associate Agreements for US work, Data Processing Agreements for EU/UK needs, and Standard Contractual Clauses for international transfers. Providers should also have ready-to-use template agreements. These templates should clearly state security duties.
Operational transparency separates strong providers from basic rack-space sellers:
- Power monitoring: Real-time visibility into actual versus provisioned capacity
- Cooling performance: Temperature and humidity logs with alerts
- Maintenance windows: 30-day advance notice with detailed procedures
- Incident reports: Notification within 4 hours of detection
Resilience also must fit residency rules. Backup immutability helps block ransomware. Disaster recovery sites must be in the same regulatory jurisdiction. At the same time, geographic separation should be more than 100 miles, while still staying inside regional boundaries.
Exit planning reduces vendor lock-in risk. Contracts should define data return timelines of 30–60 days. They should also define export formats, both native and readable. In addition, they should include secure wipe steps with certificates of destruction and processes for deleting cryptographic keys.
WhiteFiber implementation: engineered residency with matched infrastructure
WhiteFiber addresses regional PHI needs with purpose-built infrastructure. It treats residency as a system design principle.
Regional PHI pods deploy in AI-native data centers. These sites are built for the high-density power and cooling that GPU clusters require. This includes up to 150 kW per rack with direct liquid cooling.
The infrastructure includes SOC 2 Type II certification. This provides third-party validation of security controls. WhiteFiber also offers residency-scoped KMS and HSM options, so encryption keys do not leave the assigned region. Physical security includes biometric access controls, 24/7 monitoring, and mantrap entries that create audit trails.
WhiteFiber’s hybrid extension also lets organizations burst non-PHI workloads to GPU superclusters while still protecting data residency. After training models on regional PHI, organizations can run inference globally using model weights that contain no patient data. Inside each region, the high-throughput fabric delivers up to 3.2 Tb/s between nodes. This supports efficient distributed training while staying within regional limits.
As a result, organizations can combine insights across regions without exporting PHI. Statistical summaries, model parameters, and research findings can move between regions, while patient data stays protected inside residency boundaries.
FAQ: Regional Colocation for Global Trials and PHI
Do colocation providers need Business Associate Agreements for clinical trial PHI?
Can AI model weights trained on PHI be safely replicated across regions?
What audit evidence do regulators typically request for regional PHI colocation?
How does regional colocation differ from standard data center services for clinical trials?
Get a private cloud threshold assessment
Bring your dataset sizes, pipeline descriptions, compliance constraints, and current cloud bills. We will return fabric and storage sizing recommendations, utilization forecasts, and a deployment timeline that fits your operational reality.

.png)
